Lactose India Ltd (LACTOSE) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Lactose India Ltd on NSE and BSE, with an AI summary of each filing.
With reference to the Scheme of Amalgamation NCLT order dated 05th August 2026
Others (Uncategorized) · 21 Oct 2026, 5:12 pm
Lactose (India) Sets Record Date for Merger with Vitanosh Ingredients Lactose (India) Limited has fixed 2nd Nov'26 as the Record Date following NCLT Ahmedabad Bench's approval order dated 5th Aug'26 for the Scheme of Amalgamation with Vitanosh Ingredients Private Limited. Eligible equity shareholders of Vitanosh Ingredients will receive fully paid-up equity shares of Lactose (India) having a face value of INR 10 each, based on a share exchange ratio of 0.7946 equity shares of Lactose (India) for every 1 equity share held in Vitanosh Ingredients.
Pursuant to the provisions of the SEBI (LODR) Regulations, 2015 we hereby submit the voting results for the AGM held on 30th September 2026
Annual General Meeting · 02 Oct 2026, 12:49 am
Pursuant to Regulation 30 & 44(3) of SEBI (LODR) Regulations , 2015 we hereby submit the Scrutinizer Report for the AGM held on 30th September, 2026
Annual General Meeting · 02 Oct 2026, 12:44 am
Pursuant to Regulation 30 of SEBI (LODR) 2015, we hereby submit the intimation towards Appointment of Cost Auditor of the Company.
Change in Management · 30 Sept 2026, 10:25 pm
Lactose (India) Approves Alpesh A. Lakeshri as Cost Auditor for FY27 Shareholders of Lactose (India) Limited, at their meeting held on 30th Sep'26, approved the appointment of CMA Alpesh A. Lakeshri as the company's Cost Auditor for FY 2026-27. The appointment is effective 30th Sep'26 to conduct the audit of cost records for the financial year ending 31st Mar'27, pursuant to Section 148 of the Companies Act, 2013. The appointee has no inter-se relationship with any director of the company.
We hereby submit the proceedings of the 35th Annual General Meeting of the Company held on Wednesday, 30th September, 2026
Annual General Meeting · 30 Sept 2026, 10:18 pm
Pursuant to the provisions of SEBI (LODR) Regulation ,2015 , We hereby submit the intimation towards Annual General Meeting of the Company scheduled to be held on Wednesday 30th September 2026
Annual General Meeting · 08 Sept 2026, 12:36 am
Pursuant to Regulation 34(1) of SEBI (LODR) Regulations, 2015, we hereby submit the Annual Report for the FY 2025-26.
Others (Uncategorized) · 08 Sept 2026, 12:27 am
Intimation of Effective date of Amalgamation
Others (Uncategorized) · 06 Sept 2026, 1:42 am
Lactose (India) Confirms Scheme of Amalgamation with Vitanosh Ingredients Is Now Effective Lactose (India) Limited announced that the Scheme of Amalgamation with Vitanosh Ingredients Private Limited became operative and effective from 5th Sep'26. This follows the sanction of the scheme by the NCLT Ahmedabad Bench vide its order dated 20th Aug'26, under Sections 230-232 of the Companies Act, 2013. Both companies have formally filed the certified copy of the NCLT order with the respective jurisdictional Registrar of Companies on 5th Sep'26, successfully concluding the merger process.
Intimation of Effective Date of Amalgamation
Others (Uncategorized) · 06 Sept 2026, 1:38 am
Lactose (India) Announces Effective Date for Amalgamation with Vitanosh Ingredients Lactose (India) Limited has announced that its Scheme of Amalgamation with Vitanosh Ingredients Private Limited became operative and effective on 5th Sep'26. Following the approval from the Hon’ble NCLT Ahmedabad Bench vide order dated 20th Aug'26, both entities filed certified copies of the sanction order with their respective jurisdictional Registrar of Companies on 5th Sep'26, formally completing the merger under Sections 230–232 of the Companies Act, 2013.
Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015 we hereby submit the disclosure towards the Appointment of Internal Auditor And Cost Auditor.
Change in Management · 25 Aug 2026, 11:45 pm
Lactose India Appoints Internal and Cost Auditors for FY27 Lactose India's board, on 25th Aug'26, approved key auditor appointments for fiscal year 2026-27. M/s. AMS & CO LLP Chartered Accountants was re-appointed as the Internal Auditor. Additionally, Alpesh A. Lakeshri (CMA) was appointed as the Cost Auditor for the same period. Both appointments are standard corporate governance actions with no disclosed relationships between the auditors and company directors. This ensures continuity and compliance with SEBI regulations. The appointments are effective immediately for the specified fiscal year.
In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform Stock Exchange that the ....
Others (Uncategorized) · 25 Aug 2026, 11:14 pm
Lactose India Board Approves Key Appointments and FY26 Audit Reports Lactose India's board meeting on 25th Aug'26 approved several key items, including the director's and audit reports for FY26 and the Q1 FY27 internal audit report. It approved remuneration for the MD and WTD, noted the resignation of M/s. Kirit Mehta & Co as Cost Auditors, and appointed M/s. Alpesh A. Lakeshri as the new Cost Auditor for FY27. M/S. AMS & Co were re-appointed as Internal Auditors for FY27. The board also approved the 35th AGM notice and related party transactions.
In compliance with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform Stock Exchange that the ....
Others (Uncategorized) · 25 Aug 2026, 11:13 pm
Lactose India Board Approves FY26-27 Auditor Appointments and FY26 Reports The Board of Directors, in its meeting on 25th Aug'26, approved multiple audit-related items and corporate appointments. Key approvals include the Director's Report for FY26 and various audit reports for FY26 and Q1 FY27. M/s. AMS & Co. were re-appointed as internal auditors for FY27. Following the resignation of M/s. Kirit Mehta & Co., the board appointed Alpesh A. Lakeshri as the new Cost Auditor for FY27. Remuneration for the Managing Director and Whole Time Director was also approved.
Scheme of Amalgamation has been sanctioned by Hon''ble NCLT Ahmedabad Bench. The Certified True copy of the NCLT order has been received by the Company on 20th August 2026.
Others (Uncategorized) · 21 Aug 2026, 12:57 am
NCLT Approves Vitanosh Ingredients Amalgamation with Lactose India The NCLT Ahmedabad Bench sanctioned the amalgamation of Vitanosh Ingredients Pvt. Ltd. with Lactose (India) Ltd. via an order dated 05-Aug-'26. The Appointed Date for the merger is 01-Oct-'24. Following the merger, Lactose India's production capacity will increase from 10,000 MT/annum to 15,000 MT/annum. Eligible shareholders of the transferor company will receive 0.7946 equity shares of Lactose India for every 1 share held. The merger aims to enhance manufacturing capabilities, achieve economies of scale, and expand market access.
Scheme of Amalgamation has been sanctioned Hon''ble NCLT Ahmedabad Bench. The Certified True Copy of the NCLT order has been received to the Company on 20th August 2026.
Others (Uncategorized) · 21 Aug 2026, 12:53 am
NCLT Approves Amalgamation of Vitanosh Ingredients with Lactose India The NCLT Ahmedabad bench has sanctioned the Scheme of Amalgamation of Vitanosh Ingredients Pvt Ltd (Transferor) with Lactose (India) Ltd (Transferee), effective from the appointed date of 01-Oct-24. Lactose India received the certified order on 20-Aug-26. The amalgamation is expected to enhance manufacturing capabilities, increasing production capacity from 10,000 MT to 15,000 MT per annum, accelerate time-to-market, and provide larger market access. Shareholders of Vitanosh will receive 0.7946 equity shares of Lactose India for every one share held.
We are submitting the Un audited Financial Result along with Auditor report of the Company for first quarter ended as on 30th June 2026
Financial Result · 11 Aug 2026, 8:17 pm
In compliance with Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform to the Exchange ....
Outcome · 11 Aug 2026, 8:08 pm
Lactose India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve 1. To consider and approve Un-Audited ....
Intimation · 11 Aug 2026, 5:30 am
Lactose India Board to Approve Q1FY27 Results on 11th Aug'26 Lactose India Ltd. has scheduled a Board of Directors meeting for 11th Aug'26 to consider and approve the un-audited financial results for the first quarter ended 30th Jun'26. The agenda includes reviewing the Limited Review Report from the statutory auditor. In connection with this, the trading window for directors, officers, and designated employees has been closed since 01st Jul'26 and will reopen 48 hours after the results are declared.
Pursuant to Regulation 30 of SEBI (LODR)Regulations , 2015 , we hereby submit the credit rating letter received from CRISIL Ratings Limited.
Others (Uncategorized) · 14 Jul 2026, 6:14 pm
Lactose India: CRISIL Reaffirms BBB-/Stable on Enhanced Bank Facilities CRISIL has reaffirmed its 'Crisil BBB-/Stable' rating on Lactose (India) Limited's long-term bank facilities. The rating action, dated 13th Jul'26, applies to an enhanced facility amount of Rs. 90 crore, increased from Rs. 60 crore. The outlook remains stable. The rated facilities include Rs. 60 crore in cash credit from Bank of Baroda and YES Bank, and a Rs. 30 crore term loan from Bank of Baroda. The reaffirmation reflects stability in the company's credit profile despite the increased debt facility.
Considered and Approved the Forfeiture of Convertible Warrants ('Warrants') which the Company, had issued and allotted 15,00,000 Convertible Warrants, on preferential basis to following ....
Outcome · 18 Jun 2026, 9:34 pm
Lactose India Forfeits 15 Lakh Warrants, Retains INR 6.52 Crore Lactose India's board, on 18 Jun'26, approved the forfeiture of 15,00,000 convertible warrants previously allotted to SG General Dealers LLP (a non-promoter). The allottee failed to exercise their conversion rights by the 5 Jun'26 deadline. As a result, the warrants, originally issued on 5 Dec'24 at a conversion price of INR 174 per share, are now cancelled. The company will forfeit the initial consideration of INR 6,52,50,000 (25% of the total) received from the warrant holder, which will positively impact its reserves.
Lactose India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/06/2026 ,inter alia, to consider and approve 1.To forfeit 15,00,000 (Fifteen ....
Intimation · 16 Jun 2026, 12:00 am
Lactose India Board to Consider Forfeiture of 1.5 Million Warrants Lactose India's Board of Directors will meet on 18th Jun'26 to consider forfeiting 1,500,000 convertible share warrants. The warrants, allotted to M/s. SG General Dealers LLP on a preferential basis, are subject to forfeiture due to non-payment of the balance consideration required for their conversion into equity shares within the stipulated timeframe. The board will also discuss any other business items.
We hereby submit the Financial Results for the Quarter and Financial Year Ended 31st March, 2026 along with the Independent Auditor''s Report
Financial Result · 20 May 2026, 7:58 pm
LACTOSE (INDIA) LIMITED - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakhs) ■ Revenue: 4577 (+64.8% YoY | +24.5% QoQ) ■ EBITDA: 502 (+47.3% YoY | +64.0% QoQ) ■ EBITDA Margin (%): 11.0 (-130 bps YoY | +265 bps QoQ) ■ PAT: 188 (+192.3% YoY | +255.2% QoQ) ■ EPS (INR): 1.45 (+190.0% YoY | +253.7% QoQ)
In compliance with Regulation 30 and 33 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Board of ....
Outcome · 20 May 2026, 7:41 pm
LACTOSE (INDIA) LIMITED - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakhs) ■ Revenue: 4577 (+64.8% YoY | +24.5% QoQ) ■ EBITDA: 502 (+47.3% YoY | +64.0% QoQ) ■ EBITDA Margin (%): 11.0 (-130 bps YoY | +265 bps QoQ) ■ PAT: 188 (+192.3% YoY | +255.2% QoQ) ■ EPS (INR): 1.45 (+190.0% YoY | +253.7% QoQ)
Lactose India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve 1. Audited Financial Results ....
Intimation · 20 May 2026, 5:30 am
Lactose India Board Meeting to Approve Q4 & FY26 Financial Results Lactose India Ltd (BSE: 524202) has scheduled a Board of Directors meeting on 20th May'26. The primary agenda is to consider and approve the audited financial results for the fourth quarter and the full financial year ended 31st Mar'26. In connection with this, the trading window for designated persons has been closed from 1st Apr'26 and will reopen 48 hours after the results are declared.
We hereby submit our clarification on significant price movement of the company''s security. Kindly take the same on record and oblige.
Others (Uncategorized) · 29 Apr 2026, 5:43 pm
Lactose India Addresses BSE Query on Stock Price Movement In response to a clarification sought by the BSE on 24th Apr'26, Lactose India Limited stated on 29th Apr'26 that there is no pending information or announcement that could explain the significant price movement in its security. The company asserted the price action is purely due to market conditions over which it has no control or knowledge of specific reasons. It confirmed compliance with Regulation 30 of SEBI (LODR) Regulations, 2015, and committed to future required disclosures.
The Exchange has sought clarification from Lactose India Ltd on April 24, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant information ....
Others (Uncategorized) · 25 Apr 2026, 12:23 am